Detalles de la búsqueda
1.
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI).
Eur J Cancer
; 46(12): 2206-15, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20471824
Resultados
1 -
1
de 1
1
Próxima >
>>